| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q1 | Mar 31, 2025 | Harris Associates Concentrated Strategy | -0.1% | -0.1% | COP, DE, FIZN, GOOG, ICE, IQV, MOH | - | View | ||
| 2025 Q4 | Feb 10, 2026 | Kopernik Global All-Cap Fund | 8.0% | 64.8% | 015760.KS, 3690.HK, BHP, CMCSA, CNC, CVE.TO, GLEN.L, Gold, MOH, NAK, NG, PDN.AX, RGLD, RRC, SDF.DE, SEA.TO, SQM, TPK.L, TWE.AX, VALE | diversification, global, materials, Mining, Precious Metals, undervaluation, value | Gold prices rose 65% in 2025, with precious metals miners performing strongly. The fund trimmed gold positions significantly from 15% to 9% of the portfolio due to strong performance, rolling gains into platinum and industrial metals where more upside is seen. Platinum group metals producers were among the largest contributors for the second consecutive quarter. South African companies Valterra and Impala had strong returns of 20.7% and 26.4% respectively, with substantial upside potential remaining relative to risk-adjusted intrinsic value estimates. After over a decade of underperformance, value stocks had a strong fourth quarter with Russell 1000 Value up 3.3% versus 1.2% for growth. The manager believes the market is beginning to recognize value, emphasizing buying good companies for less than they are worth. Conglomerates performed well with Cresud up 48.7% and LG Corp up 9.1%. The manager notes conglomerates are complex and difficult to analyze, frequently ignored by the market, providing significant opportunities for fundamental bottom-up analysis. | IMP SJ VAL SJ |
View |
| 2025 Q3 | Oct 28, 2025 | Harris Associates Concentrated Strategy | 2.4% | 6.2% | CRM, GOOG, IQV, KDP, MOH, WBD | Artificial Intelligence, Cloud, healthcare, Media, U.S. Equities | U.S. equities rose on tech strength, with key contributors Warner Bros Discovery and Alphabet benefiting from M&A speculation and AI-driven cloud growth. IQVIAs analytics and clinical research platform also advanced due to next-gen data capabilities. While detractors included Keurig Dr Pepper and Molina Healthcare, management remains focused on concentrated, high-conviction holdings tied to AI innovation and healthcare recovery. | CRM MOH KDP IQV GOOGL WBD CRM MOH KDP IQV GOOGL WBD |
View |
| 2025 Q3 | Oct 20, 2025 | Invesco Small Cap Value Fund | 10.0% | 10.2% | AL, COHR, DAVA, EPAM, GLOB, LITE, MOH, MP, SAIA | energy, financials, industrials, small caps, Value Investing | The fund emphasizes opportunities in financials and industrials as small caps remain undervalued versus large caps. Banks and insurers benefit from stable credit quality and margin expansion, while manufacturers and service firms gain from a resilient U.S. economy. Energy holdings provide diversification and cash flow support amid moderate commodity prices. | View | |
| 2025 Q3 | Oct 10, 2025 | Oakmark Global Fund | 4.1% | 15.2% | CRM, DSY FP, HEX NO, KER FP, MOH, TRGP | Digitalization, energy, Luxury, software, value | The fund discusses positioning in global luxury brands recovering under new leadership, investments in virtual twin and AI software companies, and selective exposure to energy infrastructure. The managers view these as undervalued businesses with structural tailwinds and strong free cash flow generation. | View | |
| 2025 Q4 | Jan 20, 2026 | Meditation Capital | 0.0% | 0.0% | ELV, GTLB, MOH | AI, Health Insurance, Margins, Medicaid, technology, value | Manager outlines framework for AI investing focused on asymmetric risk/reward profiles and avoiding AI losers. Applications have lagged capex but 2026 may see value creation across portfolio. Sold GitLab position due to increased uncertainty from rapid AI coding improvements. Large positions in Elevance Health and Molina Healthcare based on margin normalization thesis after 2025 cost overruns. Health insurers expected to reprice policies to restore normal margins, creating 25-34% IRR opportunities over 4 years. | MOH ELV |
View |
| 2025 Q4 | Jan 15, 2026 | Moon Capital Management | 0.0% | 0.0% | AAPL, MOH, NVDA | Compounding, fundamentals, healthcare, Managed Care, Margins, Medicaid, value | Molina Healthcare represents a mispriced compounder experiencing transitory margin pressure in the Medicaid industry. The company serves 5.6 million members with Medicaid representing 75% of premium revenue. Despite industry-wide losses, Molina continues generating profit with MLR running 250 basis points better than industry average. | MOH |
View |
| 2024 Q2 | Jun 30, 2024 | Fidelity Growth Strategies Fund | 6.3% | 17.9% | ALGN, ALNY, MDB, MOH, VST | - | View | ||
| 2025 Q1 | Mar 31, 2025 | Oakmark Global Select Fund | 8.5% | 8.5% | GOOG, LYG, MOH, SYY | - | View | ||
| 2025 Q1 | Mar 31, 2025 | Oakmark Select Fund | -1.2% | -1.2% | GOOG, ICE, MOH | - | View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | Twitter / X | @michaeljburry | Molina Healthcare, Inc. | Health Care Providers & Services | Managed Health Care | Bull | New York Stock Exchange | Claims, GEICO, Insurance, managed care, Medicaid, Medicare, MLR, premiums, Regulation, underwriting | View Pitch |
| Feb 4, 2026 | Twitter / X | @ArmsGarrett | Molina Healthcare, Inc. | Health Care Providers & Services | Managed Health Care | Bull | New York Stock Exchange | Actuarial, buybacks, GovernmentPrograms, Healthinsurance, HMOs, Managedcare, Medicaid, MLR, Redetermination, Reimbursement | View Pitch |
| Jan 23, 2026 | Fund Letters | Timothy Liu | Molina Healthcare, Inc. | Health Care | Managed Health Care | Bull | New York Stock Exchange | buybacks, Costadvantage, Marginrecovery, Medicaid, oligopoly | View Pitch |
| Jan 21, 2026 | Fund Letters | Garrett Arms | Molina Healthcare, Inc. | Health Care | Managed Health Care | Bull | New York Stock Exchange | buybacks, managed care, margin normalization, Medicaid, Rate Resets | View Pitch |
| Nov 29, 2025 | Fund Letters | Tony Coniaris | Molina Healthcare Inc. | Health Care | Managed Health Care | Bull | NYSE | Cost control, healthcare, managed care, Medicaid, recovery, valuation | View Pitch |
| Nov 28, 2025 | Fund Letters | Tony Coniaris | Molina Healthcare Inc. | Health Care | Managed Health Care | Bull | NYSE | Cost control, healthcare, managed care, Medicaid, recovery, valuation | View Pitch |
| Oct 2, 2025 | Seeking Alpha | Seeking Alpha | Molina Healthcare, Inc. | Healthcare Plans | Bull | Acquisitions, contract wins, government-sponsored health insurance, growth prospects, managed care, Medicaid, member retention, Molina Healthcare, undervalued, valuation | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||